newsfilter
← Latest News
Business Wire·

Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update

-FB-102 Continues to Advance Towards the Clinic Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ:FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced full year 2022 results and